Overuse of proton pump inhibitors and its consequences

Direct inhibition of H+ ion excretion to the gastric lumen makes proton pump inhibitors (PPI) the most effective drugs against gastric acid-related diseases. Over recent years usage of proton pump inhibitors has increased dramatically. Due to the low costs, high efficacy and rarity of adverse effect... Ausführliche Beschreibung

1. Person: Marcin Kazberuk verfasserin
Weitere Personen: Szymon Brzósko verfasserin; Tomasz Hryszko verfasserin; Beata Naumnik verfasserin
Quelle: In Postępy Higieny i Medycyny Doświadczalnej (01.10.2016)
Weitere Artikel
Format: Online-Artikel
Sprache: English
Greek, Modern (1453- )
Veröffentlicht: 2016
Beschreibung: Online-Ressource
Online Zugang: Online
Online
Online
Online
Online
Online
Volltext
Tags: Hinzufügen
Keine Tags. Fügen Sie den ersten Tag hinzu!
  Creative Commons License Source: Directory of Open Access Journals (DOAJ).
LEADER 02085nma a2200337 c 4500
001 DOAJ023007001
003 DE-601
005 20190329212111.0
007 cr uuu---uuuuu
008 171226s2016 000 0 eng d
024 7 |a 10.5604/01.3001.0009.6889  |2 doi 
035 |a (DE-599)DOAJ318df97d04524fc9a6f7aea54c3f2888 
040 |b ger  |c GBVCP 
041 0 |a eng  |a gre 
100 0 |a Marcin Kazberuk  |e verfasserin  |4 aut 
245 1 0 |a Overuse of proton pump inhibitors and its consequences  |h Elektronische Ressource 
300 |a Online-Ressource 
520 |a Direct inhibition of H+ ion excretion to the gastric lumen makes proton pump inhibitors (PPI) the most effective drugs against gastric acid-related diseases. Over recent years usage of proton pump inhibitors has increased dramatically. Due to the low costs, high efficacy and rarity of adverse effects, their use is prevalent and often it does not correspond with existing medical guidelines. The literature lists stress ulcer prophylaxis among patients with low risk of bleeding, routine ‘gastroprotective’ medication during treatment and non-specific abdominal symptoms as the most common patterns of off-label PPI use. This article summarizes the influence of PPI therapy on gastric mucosa, absorption and occurrence of adverse effects. The authors note that their low awareness among physicians contributes to wide and imprudent use of drugs of this group. 
700 0 |a Szymon Brzósko  |e verfasserin  |4 aut 
700 0 |a Tomasz Hryszko  |e verfasserin  |4 aut 
700 0 |a Beata Naumnik  |e verfasserin  |4 aut 
773 0 8 |i In  |t Postępy Higieny i Medycyny Doświadczalnej  |g  (01.10.2016)  |w (DE-601)DOAJ000038865  |x 0032-5449 
856 4 0 |u http://dx.doi.org/10.5604/01.3001.0009.6889 
856 4 0 |y DOAJ  |u https://doaj.org/article/318df97d04524fc9a6f7aea54c3f2888 
856 4 0 |u http://phmd.pl/gicid/01.3001.0009.6889 
856 4 0 |u http://phmd.pl/gicid/pdf/01.3001.0009.6889 
856 4 0 |u https://doaj.org/toc/0032-5449 
856 4 0 |u https://doaj.org/toc/1732-2693 
912 |a GBV_DOAJ 
951 |a AR 
952 |j 2016  |b 01  |c 10 

Ähnliche Einträge

Keine ähnlichen Titel gefunden

Privacy Notice Ask a Librarian New Acquisitions